Skip to Main Content

Paper Details

Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ.
Cancer Prev Res (Phila)
1
2023
Author NameAffiliation
Judy E GarberDana-Farber Cancer Institute
Judy E GarberDana-Farber Brigham Cancer Center
Judy E GarberCenter for Cancer Genetics and Prevention, Dana-Farber Cancer Institute
Judy E GarberHarvard Medical School
Powel H BrownThe University of Texas MD Anderson Cancer Center
  • 1 - 5

Datasets

Release 1.2